FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer
Oliveira, M., Saura, C., Nuciforo, P., Calvo, I., Andersen, J., Passos-Coelho, J.L., Gil Gil, M., Bermejo, B., Patt, D.A., Ciruelos, E., de la Peña, L., Xu, N., Wongchenko, M., Shi, Z., Singel, S.M., Isakoff, S.J.
Published in Annals of oncology (01.08.2019)
Published in Annals of oncology (01.08.2019)
Get full text
Journal Article
3095 Subsequent line of therapy in metastatic NSCLC (mNSCLC): An indicator of success or failure?
Nadler, E.S, Penrod, J.R, Espirito, J.L, Wilson, T, Patt, D.A, Korytowski, B
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article